SAS-B data highlights concerning trend towards prescribing THC for anxiety by Steve Jones October 11, 2023October 11, 2023 Close to half the number of medicinal cannabis approvals in the first nine months of the […]
‘We want to rejuvenate the share price’, says ex-Vitura director as battle lines are drawn again by Steve Jones October 5, 2023October 6, 2023
Lambert Initiative in funding appeal as industry ‘pleads poverty’ over research costs by Steve Jones October 5, 2023October 5, 2023
‘On the right side of history’: clinic network snaps up leading prescribers for expansion and education drive by Martin Lane September 27, 2023October 3, 2023
MGC Pharma flags restructure in face of ‘dire alternatives’ by Martin Lane September 26, 2023September 28, 2023
Montu calls on TGA to green light the term ‘medical cannabis’ in advertising by Martin Lane September 26, 2023September 27, 2023
The media and medicinal cannabis: why we need to get it right by Hannah Adler September 21, 2023September 21, 2023
Product innovation and consistent supply are the keys to sustainable growth in Australia by Itai Rogel September 19, 2023April 30, 2024
Long-time cannabis critic says medicine’s growth ‘more concerning’ than opioid epidemic by Martin Lane September 18, 2023September 20, 2023
Cannabis executive salaries: who earned what in FY23 by Steve Jones September 13, 2023September 14, 2023
